. Author manuscript; available in PMC: 2014 Apr 1.

Published in final edited form as: Am J Med. 2013 Apr;126(4):327–335.e12. doi: 10.1016/j.amjmed.2012.10.027

Table 6.

Adverse events within 30 days of index visit^*

	Study Group			Control Group

	Baseline period	Intervention period	P	Baseline period	Intervention period	P
	N = 4355	N = 2269	P	N = 5663	N = 2951	P
Emergency department visit	59 (1.4)	29 (1.3)	0.80	77 (1.4)	42 (1.4)	0.86
Hospitalization	1 (.02)	0	1.0	3 (.05)	2 (.07)	1.0
Late antibiotic prescription^**	213 (4.9)	88 (3.9)	0.06	344 (6.1)	210 (7.1)	0.06
Late follow-up visit^**	160 (3.7)	67 (3.0)	0.13	184 (3.3)	124 (4.2)	0.02

data not available for DARTNet clinics, reflects two Denver Health study clinics and two Denver Health control clinics

^**

8 – 30 days after index visit